Gregory Woodhead, MD, PhD

Dr. Woodhead’s career objective is to translate devices and therapies from the development stage into clinical practice. His interest in cancer cell biology draws from his PhD research on the role of the catenin-signaling pathway in cell fate decisions for progenitor and cancer cells. As a resident and fellow at the University of Arizona, he embarked on an analysis of catheter-directed mechanical thrombectomy for the treatment of acute pulmonary embolism, which is a common cause of morbidity and mortality in cancer patients.

He is the principal investigator on multiple trials and registries that seek to identify long-term differences in patients who received mechanical thrombectomy for pulmonary embolism in comparison with those who received anticoagulation alone.

Dr. Woodhead has published over 50 papers and frequently presents at national and international meetings. He is an integral member of multiple institutional programs and a committee member for many professional societies. He is passionate about educating and mentoring medical students, residents and fellows. He previously served as the chair of the MD/PhD admission committee.